Sharemaestro Newsreel

Adlai Nortye Ltd (ANL) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Adlai Nortye Ltd (ANL), highlighting that analysts predict a "Buy" trend based on the ratings of 6 analysts. The target price for ANL is forecasted at USD 28.600, representing a significant upside potential. However, it notes that …

Jacobs & Co. CA Raises Position in Waters Corporation $WAT

Jacobs & Co. CA increased its stake in Waters Corporation (NYSE:WAT) by 22.6% in the second quarter, bringing its total holdings to 15,518 shares valued at $5.8 million. Waters reported strong Q2 earnings and revenue, exceeding analyst estimates, and maintained its full-year EPS guidance. …

Here are the major earnings before the open Monday

Major earnings expected before the bell on Monday include: * Barrick Mining Corporation (B [https://seekingalpha.com/symbol/B]) * Medical Properties Trust (MPT [https://seekingalpha.com/symbol/MPT]) * Seadrill Limited (SDRL [https://seekingalpha.com/symbol/SDRL]) * monday.com Ltd. (MNDY [https://seekingalpha.com/symbol/MNDY]) * Village Farms International (VFF [https://seekingalpha.com/symbol/VFF]) Other earnings slated for release before Monday's …

Should ICON’s Anthropic AI Collaboration Amid Weaker Q2 Profitability Require Action From ICON (ICLR) Investors?

ICON plc reported weaker Q2 2026 net income despite slightly higher sales, reaffirming full-year revenue guidance. Concurrently, ICON announced a multi-year collaboration with Anthropic to integrate Claude's AI into its clinical trial workflows, aiming to enhance protocol optimization and real-time monitoring. While this AI …

Insight Molecular Diagnostics Q2 2026 Earnings Preview

* Insight Molecular Diagnostics Inc. (IMDX [https://seekingalpha.com/symbol/IMDX]) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. * The consensus EPS estimate is -$0.25, [https://seekingalpha.com/symbol/IMDX/earnings/estimates] and the consensus revenue estimate is $0.44M * Over the last year, IMDX has beaten …

3 Stocks Under $50 with Open Questions

3 Stocks Under $50 with Open Questions Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable …

RadNet beats Q2 estimates, raises outlook as imaging demand surges

[Mid adult nurse during magnetic resonance exam at hospital] FG Trade Latin/E+ via Getty Images RadNet (RDNT [https://seekingalpha.com/symbol/RDNT]) on Sunday reported second-quarter revenue and earnings that topped Wall Street expectations as demand for advanced diagnostic imaging surged and its Digital Health business continued to …

Press Release: RadNet Reports Second Quarter Financial Results With Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

RadNet announced record second-quarter financial results with revenue of $428.1 million and Adjusted EBITDA of $75.5 million. The company also raised its 2026 financial guidance ranges due to the strong performance and the anticipated benefits from its continued growth and strategic initiatives. This positive …

RadNet Reports Record Second Quarter 2026 Revenue and Adjusted EBITDA, Raises Full-Year Imaging Center Guidance

RadNet, Inc. reported record financial results for the second quarter of 2026, with total revenue increasing 25% to $622.7 million and Adjusted EBITDA rising 22.7% to $99.7 million. The Digital Health segment showed substantial growth with a 56.5% revenue increase and nearly 97% surge …

BRIEF-RadNet Q2 EPS USD 0.1

RadNet reported its Q2 Earnings Per Share (EPS) as USD 0.1. The brief note from Refinitiv was published on TradingView News. To access the full article and more news, a subscription or further access might be required.

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 56.5% to a quarterly record of …

How IQVIA’s Medera Cardiac Gene Therapy Alliance and Raised 2026 Outlook Will Impact IQV (IQV) Investors

IQVIA Inc. (IQV) recently announced a collaboration with Medera Inc. to advance cardiac gene therapies and human-based drug discovery, alongside raising its full-year 2026 revenue guidance to US$17.28–US$17.48 billion. This alliance integrates IQVIA's trial execution and commercialization infrastructure with Medera's gene therapy programs, reinforcing …

Exagen Inc. (NASDAQ:XGN) Analysts Are Pretty Bullish On The Stock After Recent Results

Exagen Inc. (NASDAQ:XGN) recently surpassed its latest quarterly revenue and loss estimates, leading analysts to become more optimistic about its future. They have modestly increased their revenue and loss per share predictions for 2026 and raised the price target by 15% to US$9.86. Despite …

RadNet beats Q2 estimates, raises outlook as imaging demand surges (RDNT:NASDAQ)

RadNet (RDNT) surpassed Wall Street expectations for its second-quarter revenue and earnings, driven by a significant increase in demand for advanced diagnostic imaging and the expansion of its Digital Health segment. The company raised its full-year 2026 outlook for Imaging Center revenue and earnings, …

Charles River Laboratories International (CRL) Cuts Guidance, Is It Still Undervalued?

Charles River Laboratories International (CRL) recently cut its 2026 GAAP earnings guidance and reported a quarterly net loss, despite a strong rebound in share price momentum. The article explores two contrasting valuation narratives: one suggesting the stock is 14.7% undervalued based on primate supply …

Should Medpace’s (MEDP) Golden Cross and Upgraded Estimates Prompt a Fresh Look at Its Valuation?

Medpace Holdings (MEDP) recently experienced a "golden cross" and upward revisions to earnings estimates, indicating technical momentum and improved financial expectations. The article examines how these factors interact with the company's investment narrative, focusing on its ability to convert backlog into revenue while managing …

Adaptive Biotechnologies (ADPT) Is Up 10.5% After Raising 2026 MRD Revenue Guidance Has The Bull Case Changed?

How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook

In late July and early August 2026, IQVIA Holdings and Medera announced a collaboration pairing IQVIA's global clinical and commercialization infrastructure with Medera's Sardocor and Novoheart cardiac gene therapy and human-based drug discovery platforms, alongside IQVIA's second-quarter results, raised full-year 2026 revenue guidance to …

Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX

Seilern Investment Management Ltd increased its stake in IDEXX Laboratories, Inc. by 20.7% in the second quarter, purchasing an additional 16,729 shares. The firm now holds 97,560 shares valued at approximately $51.4 million, making IDEXX its fifth-largest position. IDEXX Laboratories reported strong quarterly results, …

What Labcorp Holdings (LH)'s New PTEN Test and Guidance Hike Means For Shareholders

Labcorp Holdings recently announced the nationwide availability of Roche's FDA-approved VENTANA PTEN (SP218) RxDx Assay, a diagnostic tool for prostate cancer, along with increased quarterly sales and an uplift in its full-year 2026 revenue growth guidance. This move strengthens Labcorp's position in precision oncology …

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus

Wall Street’s major market averages ended higher on Friday after July's nonfarm payrolls surprised to the downside, showing an unexpected contraction in employment. The blue-chip Dow edged up 0.3%, the benchmark S&P 500 gained 0.62%, and the tech-focused Nasdaq Composite jumped 1.3%. The S&P …

Danaher Announces New CEO to Drive Enterprise Growth

Julie Sawyer Montgomery will become the new CEO of Danaher in October 2026, succeeding Rainer Blair, who will retire but remain as a senior advisor. Montgomery, who has been with Danaher since 2017 and oversaw significant growth in its Diagnostics business, will focus on …

Will Raised 2026 Revenue Guidance and Diagnostics Strength Change Revvity's (RVTY) Narrative

Revvity, Inc. recently reported strong Q2 2026 results, including increased revenue guidance and robust Diagnostics performance, leading to a reaffirmed quarterly dividend. Management attributes this positive outlook to improved pharma and biotech demand and a strategic exit from its China immunodiagnostics business. This shift …

GoalVest Advisory LLC Sells 2,440 Shares of Thermo Fisher Scientific Inc. $TMO

Polianta Ltd Acquires New Stake in Icon Plc $ICLR

Polianta Ltd has acquired a new stake in Icon Plc (NASDAQ:ICLR) during the second quarter of 2026, purchasing 10,800 shares valued at approximately $1.876 million. Institutional investors and hedge funds now own 95.61% of the company. Analysts maintain a consensus "Hold" rating on ICLR, …

Legacy Wealth Management LLC MS Sells 1,917 Shares of Thermo Fisher Scientific Inc. $TMO

Seilern Investment Management Ltd Lowers Stake in Mettler-Toledo International, Inc. $MTD

Seilern Investment Management Ltd reduced its stake in Mettler-Toledo International, Inc. by 6.6% in the second quarter, selling 1,477 shares and retaining 21,057 shares valued at approximately $26.9 million. Despite this, other institutional investors increased their holdings, with overall institutional ownership reaching 95.07%. Mettler-Toledo …

Natera (NTRA) Is Up 20.3% After Raising 2026 Guidance And Expanding Signatera’s Oncology Reach

Mettler-Toledo International, Inc. $MTD Shares Acquired by PensionDanmark Pensionsforsikringsaktieselskab

PensionDanmark Pensionsforsikringsaktieselskab significantly increased its stake in Mettler-Toledo International (NYSE:MTD) by 27.4% in the second quarter, bringing its total holdings to 7,342 shares valued at approximately $9.4 million. This move is part of broader institutional investment, as hedge funds and other institutional investors own …

Price to earnings forward of Prenetics Global Limited – NASDAQ:PRE

Renaissance Technologies LLC Acquires Shares of 239,800 Adaptive Biotechnologies Corporation $ADPT

Renaissance Technologies LLC has acquired 239,800 shares of Adaptive Biotechnologies Corporation, valued at approximately $3.33 million, marking a new stake in the company. Institutional investors collectively hold 99.17% of Adaptive Biotechnologies. The company reported better-than-expected quarterly revenue but missed earnings estimates, while analysts maintain …

63,219 Shares in Qiagen N.V. $QGEN Bought by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company recently acquired 63,219 shares of Qiagen N.V. (NYSE:QGEN) worth approximately $2.52 million. This purchase is part of broader institutional investment, with various firms like Boston Partners, Norges Bank, and Price T Rowe Associates also holding significant stakes, bringing total …

Does BillionToOne’s (BLLN) Profitability Turn and Reaffirmed 2026 Outlook Redefine Its Core Investment Story?

Mettler-Toledo International, Inc. $MTD Shares Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly increased its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 161.1% in the second quarter, now owning 33,608 shares valued at $42,935,000. This comes as other institutional investors also adjusted their holdings, and company insiders sold shares totaling over $4.75 …

IDEXX Laboratories Inc (HAM:IX1) Stock Price & 30 Year Financial Data

This article provides comprehensive 30-year financial data for IDEXX Laboratories Inc (HAM:IX1), including growth rates for revenue, EPS, EBIT, EBITDA, and free cash flow. It details key financial metrics such as Market Cap, Enterprise Value, PE Ratio, PB Ratio, and GF Score, offering an …

Natera (NTRA) Is Up 20.3% After Shelf Filing And Higher 2026 Guidance Has The Bull Case Changed?

In early August 2026, Natera filed an US$849.22 million shelf registration for 3,200,000 common shares tied to its employee stock plans, shortly after reporting record quarterly test volumes and raising full-year 2026 revenue guidance to US$2.85 billion–US$2.91 billion. The company's push to expand regulatory …